- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Anticonvulsants Market Overview

The anticonvulsants market is set to strengthen its position at a lower CAGR of 2.4% during the forecast period. The market holds the revenue of US$ 25.17 Bn in 2023 while it is likely to cross a value of US$31.91 Bn by 2033.

Attributes Details
Anticonvulsants Market Size (2023E) US$ 25.17 Billion
Anticonvulsants Projected Size (2033F) US$ 31.91 Billion
Value CAGR (2023 to 2033) 2.4%

Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures.

Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used in treatment of bipolar disorder and in neuropathic pain management.

Anyone could potentially have a single epileptic seizure at some point in their lives. This is not the same as having epilepsy, which is a tendency to have seizures that start in the brain. Epilepsy can affect people of any age group. Though brain injury, brain cancer, drug and alcohol misuse and stroke are some of the reasons for epileptic seizures, the exact reason for convulsions is not known.

Some of the common symptoms which occur before convulsions include, visual loss, strange feeling, nausea, numbness in body parts, headache and racing thoughts.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Anticonvulsants Market: Overview

Anticonvulsant drugs are in high demand due to the higher occurrence of epileptic seizures that are caused by the disturbance in the electrical activity in the brain. This involves small attacks that shake the brain. The complex treatment is getting eased through research and development in neurology. Higher modern-healthcare technology is adding new developments, such as advanced barbiturates and other antiepileptic drugs.

Increasing awareness about the anticonvulsants available in the market and the patent expiration of many blockbuster drugs are some of the major factors that are driving the global anticonvulsants market.

The generic medication for the treatment of epilepsy through anticonvulsants is a long process and can only be processed through specific treatments along with efficacious drugs made by different pharma giants. Although, generic medicines have not been that successful in terms of effectiveness.

Anticonvulsants Market: Growth Determinants

The geriatric population and their screen addictions involve long hours of mobile and laptop usage, increasing the chances of epilepsy and convulsion conditions.

The common symptoms involve visual loss, strange feelings, nausea, headache, numbness in the body, and racing thoughts. Through these conditions, the convulsions are tracked. Companies make anticonvulsants according to specific conditions.

These factors are responsible for fueling the market for Anticovaculants.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Restraint for the Anticonvulsants Market

The traditional practices and long and high-cost treatment has led to the slowdown of the anticonvulsants market. The side effects of anti-seizure medications with liver and skin conditions also limit the demand for anticonvulsants.

The New Antiepileptic Drugs & Clinical Indications

The major clinical indications that lead to seizure conditions are discussed as follows:


The high blood sugar levels that are common in diabetes can easily damage nerves throughout your body. The first symptom generally can be numbness and pain in the hands and feet, which is also known as diabetic neuropathy.


People with conditions such as shingles are at risk of developing postherpetic neuralgia. This happens when the pain from shingles persists after the rash disappears.


Some chemotherapy drugs can damage nerves, causing pain and numbness that generally begins in the tips of your toes and fingers (neuropathy). This involves the condition of different epileptic conditions, fueling the demand for anticonvulsant drugs.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Anticonvulsants Market: Drivers and Restraints

Increasing awareness about the anticonvulsants available in the market, patent expiration of many blockbuster drugs are some of the major factors that are driving the global anticonvulsants market towards growth. There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the US by FDA. Moreover, three trends involving consumption of AEDs have become clinically important and must be considered by all who treat patients with epilepsy.

These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. While, high costs and unavailability of convenient dosage forms of both generic and branded anticonvulsants are restraining the growth of novel therapies in the anticonvulsants market.

Anticonvulsants Market: Overview

Seizures are expected to result in physical, psychological and social repercussions. People with epilepsy could adhere rigorously to their medication regimes in order to prevent these deleterious outcomes. Treatment of epileptic seizures has led to the growth of anticonvulsants market. Barbiturates were the first antiepileptic drugs. These are more effective and tolerable than bromides.

Hydantoins are the first to be known as modern antiepileptic drugs. Succinimides are an old group of drug which are rarely prescribed nowadays. Consequently with these antiepileptic or antiseizure drugs, anticonvulsants market is growing immensely leaving a significant impact on the treatment of epileptic seizures.

The antiepileptic drug market is threatened by generic completion, which has been increasing dramatically in the face of patent expirations among several of the major branded antiepileptics. However, there have been cases where generic antiepileptic drugs have not been as efficacious as their branded counterparts have.

Anticonvulsants Market: Region-wise Outlook

Region wise, the global anticonvulsants marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Currently, North America dominates the anticonvulsants market followed by Europe. Asia-Pacific is expected to emerge as a lucrative region, owing to factors such as increasing healthcare spending, improving healthcare infrastructure, and increasing demand for drugs. Given these factors, the market for anticonvulsants is likely to grow rapidly in Asia-Pacific region.

Anticonvulsants Market: Key Players

Some of the key players, contributing to global anticonvulsants drug market, are Johnson & Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc, Pfizer Inc., Abbott Laboratories, Cephalon Inc. and Shire plc. Pfizer has been estimated to cover the largest market share in the antiepileptic market, accounting for close to one-third of total revenues of the market with it two leading brands.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  •  Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Anticonvulsants Market: Segmentation

Anticonvulsants market is segmented based on product type, application, end user and geography.

Based on product type, the anticonvulsants market is segmented as follows:

  • Barbiturates
  • Aldehydes
  • Benzodiazepines
  •  Aromatic allylic alcohols
  • Carboxamides
  • Bromides
  • Carbamates
  • Sulfonamides
  • Fructose derivatives
  • Pyrrolidines
  • Triazines
  • Fatty acids
  • Oxazolidinediones
  • Ureas
  • GABA analogs
  • Propionates
  • Hydantoins
  • Pyrimidinediones
  • Valproylamides (amide derivatives of valproate)
  • Others

Based on application, the anticonvulsants market is segmented as follows:

  • Epilepsy
  • Fibromyalgia
  • Migraine
  • Neuropathic pain
  • Bipolar disorder
  • Anxiety
  • Borderline personality disorder

Based on end user, the anticonvulsants market is segmented as follows:

  • Hospitals
  • Clinics
  • Ambulatory surgical clinics

Frequently Asked Questions

What is the Growth Outlook for Anticonvulsants Market?

The market is likely to register a CAGR of 2.4% through 2032.

What is the Current Valuation of the Anticonvulsants Market?

The market is currently valued at US$ 25.17 Bn in 2022.

How is the Future of the Anticonvulsants Market?

The market is likely to grow to a valuation of US$ 31.91 Bn by 2032.

Which is the Leading Region in the Market?

North America is likely to be a leading market during the forecast period.

Explore Healthcare Insights

View Reports

Anticonvulsants Market

Schedule a Call